ArticleBMC cardiovascular disorders2024

Unraveling the rapid progression of non-target lesions: risk factors and the therapeutic potential of PCSK9 inhibitors in post-PCI patients.

Jiajie Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.